News

The research will be advanced through the integration of cryo-electron microscopy (EM), nuclear magnetic resonance (NMR) spectroscopy, and X-ray diffraction (XRD) which are believed to progress key medical

Under the terms of the collaboration, both the companies will develop novel drug candidates against multiple targets across different therapeutic areas. Initially, NovAliX will employ its protein biochemistry

rIX-FP is indicated for the prophylaxis and treatment of bleeding episodes in patients with congenital Factor IX (FIX) deficiency. CSL Behring Global Clinical R&D senior vice president Russell

Gleevec is the registered trade name for Imatinib, a specific inhibitor of tyrosine kinase BCR-ABL. BCR-ABL is a fusion protein created by the Philadelphia Chromosome abnormality that characterizes

NIOX MINO enables management of airway inflammation and thus is believed to play a critical role in effective diagnosis, treatment and follow-up of patients with inflammatory airway diseases

The upgradation includes adoption of Oracle Argus Safety 7.0, a safety database and regulatory reporting system. Oracle Argus Safety is believed to help Novella provide efficiencies and the

According to the company, the supplements which largely cater to health-conscious families, travelers and fitness enthusiasts have been developed a result of rise in demand for wellness supplements.

The process involves non-enzymatic method for deriving stromal vascular fraction from 60cc’s of adipose tissue, which is believed to increase the yield in manufacturing stromal vascular fraction compared

Alpha Lipoic Acid Capsule (ALA), also known as Thioctic Acid, is an antioxidant product that addresses diabetic neuropathy. The company will be one of the two pharmaceutical companies